2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts
Posted inDiabetes & Endocrinology news Oncology

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts

A retrospective study of 670 papillary thyroid carcinoma patients validates the 2025 ATA risk stratification system, demonstrating a shift toward higher-risk classifications. The new 'low-intermediate-risk' class emerges as a distinct entity with intermediate structural disease persistence risk, warranting dedicated prospective management studies.
AI Models for EGFR Prediction in Lung Cancer Show Ancestry-Based Performance Gaps
Posted innews Oncology Pathology & Lab Medicine/Bệnh học

AI Models for EGFR Prediction in Lung Cancer Show Ancestry-Based Performance Gaps

A cohort study reveals that open-source AI pathology models predicting EGFR mutations in lung adenocarcinoma demonstrate variable performance across ancestral groups, with notably lower accuracy in Asian patients (AUC 0.68) compared to European (AUC 0.84) and African (AUC 0.85) populations, raising important considerations for equitable clinical deployment.
ICG Fluorescence-Guided Lymphadenectomy Shows Promise in Improving Lymph Node Detection During Esophagectomy for Esophageal Cancer
Posted inGeneral Surgery news Oncology

ICG Fluorescence-Guided Lymphadenectomy Shows Promise in Improving Lymph Node Detection During Esophagectomy for Esophageal Cancer

A prospective cohort study of 30 patients demonstrates that indocyanine green near-infrared fluorescence imaging during minimally invasive esophagectomy achieves 80% sensitivity and 99.4% negative predictive value for detecting malignant lymph nodes, offering a complementary mapping tool for enhanced surgical precision.
Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial
Posted inGastroenterology news Oncology

Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial

The NIVOLEP phase 2 trial demonstrates that perioperative nivolumab (neoadjuvant and adjuvant) combined with irreversible electroporation achieves 70.6% one-year local recurrence-free survival in BCLC A HCC patients with high recurrence risk. Pathological response correlated with immune activation pathways, suggesting synergistic effects between immunotherapy and ablation.
Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes
Posted innews OB/GYN & Women's Health Oncology

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes

A real-world study of 671 endometrial cancer patients reveals significant molecular heterogeneity. PTEN, ARID1A, and PIK3CA are the most prevalent biomarkers, while TP53 mutations and ERBB2 amplification cluster in advanced-stage and non-endometrioid tumors. The findings underscore the need for comprehensive molecular profiling to guide personalized treatment strategies.